Drug class in one race
Dopamine D2/D3 and serotonin 5-HT1A receptor drugs for Alzheimer's Disease
2 tracked Dopamine D2/D3 and serotonin 5-HT1A receptor drugs in the Alzheimer's Disease race. The class explanation lives on the Dopamine D2/D3 and serotonin 5-HT1A receptor page; the full indication pipeline across every mechanism is on the Alzheimer's Disease page.
1 approved / phase 41 Phase 2
Head-to-head evidence: Brexpiprazole (Rexulti) vs ITI-1284